Srinivas Lankalapalli

920 total citations
54 papers, 627 citations indexed

About

Srinivas Lankalapalli is a scholar working on Pharmaceutical Science, Molecular Biology and Analytical Chemistry. According to data from OpenAlex, Srinivas Lankalapalli has authored 54 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmaceutical Science, 14 papers in Molecular Biology and 11 papers in Analytical Chemistry. Recurrent topics in Srinivas Lankalapalli's work include Drug Solubulity and Delivery Systems (17 papers), Advanced Drug Delivery Systems (13 papers) and Analytical Methods in Pharmaceuticals (11 papers). Srinivas Lankalapalli is often cited by papers focused on Drug Solubulity and Delivery Systems (17 papers), Advanced Drug Delivery Systems (13 papers) and Analytical Methods in Pharmaceuticals (11 papers). Srinivas Lankalapalli collaborates with scholars based in India and United States. Srinivas Lankalapalli's co-authors include Venkata Ramana Murthy Kolapalli, R. Sujatha, Jagadeesh Panda, L. V. Venkataraman, M. S. Narayan, K. Akhilender Naidu, G. A. Ravishankar, Nancy H. Colburn, Thomas D. Gindhart and Mukthinuthalapati Mathrusri Annapurna and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Toxicology in Vitro.

In The Last Decade

Srinivas Lankalapalli

47 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Srinivas Lankalapalli India 12 171 151 106 88 76 54 627
Jan Steenekamp South Africa 15 289 1.7× 139 0.9× 123 1.2× 100 1.1× 46 0.6× 34 716
Meenakshi Bhatia India 15 280 1.6× 97 0.6× 142 1.3× 128 1.5× 68 0.9× 46 719
Yanting Huang China 10 145 0.8× 281 1.9× 66 0.6× 51 0.6× 115 1.5× 32 896
María Cristina Martínez-Ohárriz Spain 17 335 2.0× 118 0.8× 119 1.1× 77 0.9× 173 2.3× 36 670
Kok-Khiang Peh Malaysia 13 335 2.0× 119 0.8× 69 0.7× 84 1.0× 69 0.9× 21 630
Gyiae Yun South Korea 8 441 2.6× 145 1.0× 134 1.3× 88 1.0× 212 2.8× 12 894
Basavaraj K. Nanjwade India 16 346 2.0× 334 2.2× 186 1.8× 61 0.7× 113 1.5× 57 997
Maria Elenir Nobre Pinho Ribeiro Brazil 14 86 0.5× 116 0.8× 172 1.6× 111 1.3× 78 1.0× 61 706
Jieun Ro South Korea 7 410 2.4× 149 1.0× 131 1.2× 99 1.1× 217 2.9× 14 892
Kifayat Ullah Khan Pakistan 14 344 2.0× 76 0.5× 178 1.7× 49 0.6× 45 0.6× 35 633

Countries citing papers authored by Srinivas Lankalapalli

Since Specialization
Citations

This map shows the geographic impact of Srinivas Lankalapalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srinivas Lankalapalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srinivas Lankalapalli more than expected).

Fields of papers citing papers by Srinivas Lankalapalli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srinivas Lankalapalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srinivas Lankalapalli. The network helps show where Srinivas Lankalapalli may publish in the future.

Co-authorship network of co-authors of Srinivas Lankalapalli

This figure shows the co-authorship network connecting the top 25 collaborators of Srinivas Lankalapalli. A scholar is included among the top collaborators of Srinivas Lankalapalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srinivas Lankalapalli. Srinivas Lankalapalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lankalapalli, Srinivas, et al.. (2025). Plant-Based Exosomes: Insights and Therapeutic Applications. Critical Reviews in Therapeutic Drug Carrier Systems. 43(1). 1–55.
3.
Lankalapalli, Srinivas, et al.. (2024). DEVELOPMENT AND EVALUATION OF CYCLODEXTRIN NANOSPONGES-BASED TOPICAL FORMULATION OF TAZAROTENE. International Journal of Applied Pharmaceutics. 90–97.
4.
Lankalapalli, Srinivas, et al.. (2023). DESIGN OF EXPERIMENTS AND OPTIMIZATION OF AMORPHOUS SOLID DISPERSION OF A BCS CLASS IV ANTI-PLATELET DRUG THROUGH FACTORIAL DESIGN. International Journal of Applied Pharmaceutics. 353–364. 2 indexed citations
5.
Lankalapalli, Srinivas, et al.. (2019). SOLUBILITY AND DISSOLUTION ENHANCEMENT OF IVACAFTOR TABLETS BY USING SOLID DISPERSION TECHNIQUE OF HOT-MELT EXTRUSION - A DESIGN OF EXPERIMENTAL APPROACH. Asian Journal of Pharmaceutical and Clinical Research. 12(1). 356–356. 19 indexed citations
6.
Lankalapalli, Srinivas, et al.. (2016). Formulation and Evaluation of Rifampicin Liposomes for Buccal Drug Delivery. Current Drug Delivery. 13(7). 1084–1099. 10 indexed citations
7.
Lankalapalli, Srinivas, et al.. (2015). Formulation and evaluation of floating in situ gelling system of losartan potassium. Der pharmacia lettre. 7(1). 98–112. 6 indexed citations
8.
Lankalapalli, Srinivas, et al.. (2015). Preparation and evaluation of liposome formulations for poorly soluble drug itraconazole by complexation. Der pharmacia lettre. 7(8). 1–17. 4 indexed citations
9.
Lankalapalli, Srinivas, et al.. (2014). NEW VALIDATED UV SPECTROPHOTOMETRIC METHODS FOR THE DETERMINATION OF FEBUXOSTAT IN BULK AND FORMULATION. 3 indexed citations
10.
Lankalapalli, Srinivas, et al.. (2014). NANOPARTICULATE DRUG DELIVERY SYSTEMS: PROMISING APPROACHES FOR DRUG DELIVERY. Journal of Drug Delivery and Therapeutics. 0(0). 3 indexed citations
11.
Lankalapalli, Srinivas, et al.. (2013). Formulation and evaluation of ibuprofen pulsin cap technique for controlled release. Der pharmacia lettre. 5(1). 60–68. 6 indexed citations
12.
Lankalapalli, Srinivas, et al.. (2013). Design development and evaluation of citicoline controlled release tablets. Der pharmacia lettre. 5(1). 296–311. 1 indexed citations
13.
Annapurna, Mukthinuthalapati Mathrusri, et al.. (2012). Development and validation of the stability-indicating LC–UV method for the determination of Cefditoren pivoxil. Journal of Pharmaceutical Analysis. 2(6). 466–469. 8 indexed citations
14.
Lankalapalli, Srinivas & Kolapalli Venkata Ramana Murthy. (2010). Preparation and evaluation of polyelectrolyte complexes for oral controlled drug delivery. Asian Journal of Pharmaceutics. 4(1). 69. 3 indexed citations
15.
Rao, Battula Sreenivasa, et al.. (2004). Design and evaluation of Eudragit RL 100 sintered matrix tablets. Indian Journal of Pharmaceutical Sciences. 66(2). 202–207. 7 indexed citations
16.
Chowdary, K. P. R. & Srinivas Lankalapalli. (2000). Physical Stability And Dissolution Rate of Ibuprofen Suspensions Formulated Employing Its Solid Dispersions. Indian Journal of Pharmaceutical Sciences. 62(4). 253. 3 indexed citations
17.
Narayan, M. S., K. Akhilender Naidu, G. A. Ravishankar, Srinivas Lankalapalli, & L. V. Venkataraman. (1999). Antioxidant effect of anthocyanin on enzymatic and non-enzymatic lipid peroxidation. Prostaglandins Leukotrienes and Essential Fatty Acids. 60(1). 1–4. 45 indexed citations
18.
Sujatha, R. & Srinivas Lankalapalli. (1995). Modulation of lipid peroxidation by dietary components. Toxicology in Vitro. 9(3). 231–236. 27 indexed citations
19.
Lankalapalli, Srinivas, et al.. (1983). Membrane and genetic events in tumor promotion: studies with promoter resistant variants of JB6 cells.. PubMed. 14. 155–66. 3 indexed citations
20.
Lankalapalli, Srinivas, et al.. (1976). Studies on urinary arylsulphatase activity in vitamin A deficient rats.. CFTRI Institutional Repository. 46(1). 3–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026